Protagonist Therapeutics Inc (PTGX)

Financial leverage ratio

		Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019
Total assets	US$ in thousands	629,276	357,951	330,016	320,466	239,858	247,928	282,174	310,512	348,296	347,695	373,175	404,232	298,072	324,468	217,320	224,980	134,901	154,917	154,627	148,105
Total stockholders’ equity	US$ in thousands	560,444	336,677	302,149	294,068	216,167	215,608	243,616	267,978	301,778	300,021	329,660	357,447	259,334	279,606	169,590	167,485	62,666	79,964	95,358	84,316
Financial leverage ratio		1.12	1.06	1.09	1.09	1.11	1.15	1.16	1.16	1.15	1.16	1.13	1.13	1.15	1.16	1.28	1.34	2.15	1.94	1.62	1.76

March 31, 2024 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $629,276K ÷ $560,444K
= 1.12

The financial leverage ratio of Protagonist Therapeutics Inc has shown fluctuations over the past few quarters. The ratio increased steadily from Jun 2020 to Mar 2021, reaching a peak of 2.15 in Mar 2020, indicating high financial leverage during that period. However, from Mar 2021 onwards, the ratio started to decrease steadily, with occasional fluctuations, reaching a low of 1.06 in Dec 2023. This decrease suggests a reduction in financial risk and reliance on debt financing. Overall, the trend indicates that the company has been managing its debt levels effectively and has gradually improved its financial leverage position.